EP Patent

EP1165061B1 — Verwendung eines kombinationspräparates aus vitamin-d-metaboliten oder vitamin-d-analoga und eines östrogenpartialagonisten zur behandlung von osteoporose

Assigned to Bayer Pharma AG · Expires 2005-10-19 · 21y expired

What this patent protects

Patent listed against Rayaldee.

Drugs covered by this patent

Patent Metadata

Patent number
EP1165061B1
Jurisdiction
EP
Classification
—
Expires
2005-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.